Security National Bank of Sioux City Iowa IA Raises Holdings in Colgate-Palmolive Company $CL

Security National Bank of Sioux City Iowa IA increased its stake in shares of Colgate-Palmolive Company (NYSE:CLFree Report) by 37.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,198 shares of the company’s stock after acquiring an additional 6,052 shares during the period. Security National Bank of Sioux City Iowa IA’s holdings in Colgate-Palmolive were worth $2,035,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of CL. Geode Capital Management LLC grew its stake in shares of Colgate-Palmolive by 1.4% during the 4th quarter. Geode Capital Management LLC now owns 22,103,901 shares of the company’s stock worth $1,754,657,000 after purchasing an additional 304,426 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of Colgate-Palmolive by 8.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 13,532,417 shares of the company’s stock valued at $1,240,652,000 after purchasing an additional 1,010,872 shares during the period. Norges Bank purchased a new stake in Colgate-Palmolive during the fourth quarter worth $861,670,000. Deutsche Bank AG boosted its holdings in Colgate-Palmolive by 33.9% during the fourth quarter. Deutsche Bank AG now owns 10,845,857 shares of the company’s stock worth $857,040,000 after buying an additional 2,746,920 shares in the last quarter. Finally, First Eagle Investment Management LLC grew its position in Colgate-Palmolive by 1.1% during the second quarter. First Eagle Investment Management LLC now owns 8,205,699 shares of the company’s stock valued at $752,298,000 after buying an additional 88,917 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CEO Noel Wallace sold 161,021 shares of the business’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the transaction, the chief executive officer directly owned 362,231 shares in the company, valued at approximately $33,296,273.52. The trade was a 30.77% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director John Cahill sold 4,170 shares of the company’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $93.37, for a total transaction of $389,352.90. Following the sale, the director directly owned 28,373 shares of the company’s stock, valued at approximately $2,649,187.01. This represents a 12.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 175,191 shares of company stock worth $16,110,903. 0.43% of the stock is owned by insiders.

Colgate-Palmolive Price Performance

Shares of CL traded down $0.23 during trading hours on Friday, hitting $87.50. 10,838,202 shares of the stock were exchanged, compared to its average volume of 5,744,471. The stock’s 50-day moving average price is $90.88 and its two-hundred day moving average price is $89.27. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.67 and a current ratio of 1.03. The company has a market cap of $69.75 billion, a price-to-earnings ratio of 34.72, a price-to-earnings-growth ratio of 4.06 and a beta of 0.33.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings data on Friday, July 31st. The company reported $0.99 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.04. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%.The company had revenue of $5.36 billion for the quarter, compared to analyst estimates of $5.36 billion. During the same quarter last year, the firm posted $0.92 EPS. The firm’s revenue for the quarter was up 4.9% on a year-over-year basis. Research analysts expect that Colgate-Palmolive Company will post 3.87 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be paid a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend is Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 84.13%.

Analyst Ratings Changes

A number of research analysts have weighed in on CL shares. Piper Sandler lifted their price objective on shares of Colgate-Palmolive from $92.00 to $96.00 and gave the company an “overweight” rating in a report on Thursday, July 9th. Citigroup increased their target price on shares of Colgate-Palmolive from $105.00 to $110.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Weiss Ratings upgraded Colgate-Palmolive from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday. Royal Bank Of Canada restated an “outperform” rating and issued a $104.00 price target on shares of Colgate-Palmolive in a research note on Tuesday, September 8th. Finally, Morgan Stanley reiterated an “overweight” rating and set a $104.00 price target on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Thirteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $99.00.

Read Our Latest Analysis on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company (NYSE:CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its products are sold in more than 200 countries and territories through retail stores, e-commerce channels and professional networks.

The company’s portfolio includes Colgate toothpaste, toothbrushes and mouthwashes; Palmolive and Softsoap personal care products; Ajax and other household cleaning products; and Hill’s Science Diet and Prescription Diet pet foods.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.